TSS
DERM icon

Two Sigma Securities’s Journey Medical DERM Stock Holding History

Two Sigma Securities’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,016
Closed -$19.1K – 3035
2023
Q2 		$19.1K Buy
+12,016
New +$19.3K ﹤0.01% 2516

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's DERM Position: Q3 2023 in Review

Two Sigma Securities sold out of Journey Medical (DERM) in Q3 2023, closing a stake of 12,016 shares — an estimated $19.1K sold.

Two Sigma Securities first reported a position in DERM in Q2 2023 and held it in 1 quarter. The position peaked at $19.1K in Q2 2023. 21 funds tracked by Wall St. Rank hold DERM as of Q3 2023.

  • Two Sigma Securities reported no remaining Journey Medical position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 12,016 Journey Medical shares in Q3 2023, an estimated $19.1K.
  • Two Sigma Securities first reported a position in Journey Medical in Q2 2023 and held it in 1 quarter.
  • Two Sigma Securities's Journey Medical position peaked at $19.1K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Journey Medical as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.